Pancreatic Stenting Reduces Post-ERCP Pancreatitis and Biliary Sepsis in High-Risk Patients: A Randomized, Controlled Study

Table 3

PEP and other ERCP-associated morbidities.

	Experimental group ()	Control group ()
PEP, (%)	8 (7.7)	18 (17.7)	0.031
PEP recovery time, d, mean ± SD	3.0 ± 1.2	3.1 ± 2.0	0.829
Time to resume oral intake, d, mean ± SD	3.2 ± 1.8	3.5 ± 1.6	0.765
Postoperative hospital stay, d, mean ± SD	8.8 ± 3.5	8.5 ± 4.1	0.552
Postoperative bleeding, (%)	0 (0.0)	1 (1.0)	0.311
Postoperative perforation, (%)	0 (0.0)	0 (0.0)	N/A
Postoperative infection, (%)	0 (0.0)	0 (0.0)	N/A
Second-look ERCP	1 (1.0)	0 (0.0)	0.321
PDS displacement, (%)	4 (3.9)	N/A	N/A
Mortality, (%)	0 (0.0)	0 (0.0)	N/A

N/A: not applicable.